KINETICS OF ELIMINATION

1. SIVANAGESWARARAO MEKALA ASSISTANT PROFESSOR DEPT OF CLINICAL PHARMACOLOGY KINETICS OF ELIMINATION

2. The four most important parameters governing drug disposition are : • clearance • volume of distribution • half-life • bioavailability

3. Clearance (CL): The clearance of a drug is the theoretical volume of plasma from which the drug is completely removed in unit time. Clearance (CL) = __Rate of elimination___ Plasma conc. of the drug

4. When clearance is constant, the rate of drug elimination is directly proportional to drug concentration. KINETICS OF ELIMINATION: • Zero order • First order

5. For most drugs, clearance is constant over the concentration range encountered in clinical settings, and the rate of drug elimination is directly proportional to concentration • This is referred to as first-order elimination. • Here a constant fraction of drug present in the body is eliminated in unit time • The t1/2 of the drugs will always remain constant FIRST ORDER KINETICS:

6. For first order kinetics, Clearance is calculated from the dose divided by the AUC • CL = Dose AUC Half life of a drug following first order kinetics would remain constant irrespective of dose

7. The rate of elimination remains constant irrespective of drug concentration OR • a constant amount of drug is eliminated in unit time ZERO ORDER OR CAPACITY LIMITED KINETICS

8. Rate of elimination is constant and is unrelated to the amount of drug in the body. • 1hr 10mg • 2hr 20mg • 3hr 30mg • 10hr 100mg • e.g.-ethyl alcohol • Zero order kinetics – t ½  with dose since CL progressively  as dose is increased. ZERO ORDER (LINEAR) KINETICS:

9. Half life of the drug is never constant

10. Phenytoin Tolbutamide Theophylline Warfarin Aspirin FIRST ORDER TO ZERO ORDER

11. Phenytoin, Aspirin ↓ At low doses, follow first order kinetics As the plasma conc. increases Elimination processes get saturated ↓ Kinetics changes over to zero order (saturation kinetics)

12. Plasma half life It is the time required for the plasma concentration of the drug to decrease by 50% of its original value . Initial rapidly declining (α) phase – due to distribution Later less declined (β) phase – due to elimination At least two half-lives (distribution t1/2 and elimination t1/2) can be calculated from the two slopes. The elimination half-life derived from the β slope is simply called the half life of the drug .

13. Mathematically ,elimination t1/2 is = ln2/k * ln2 is the natural logarithm of 2 (or 0.693) * k is the elimination rate constant of the drug. i.e. the fraction of the total amount of the drug in the body which is removed per unit time . Eg: 2g of drug present in the body & 0.1g is eliminated every hour then k =0.1/2=0.05 or 5% per hour . k=CL/v , therefore t1/2 =0.693xV/CL

14. 1 t1/2 = 50% drug is eliminated ; 2 t1/2 = 75% ; (50% + 25%) 3 t1/2 = 87.5% ; ( 75% +12.5%) 4 t1/2 = 93.75% (87.5% + 6.25%) Nearly complete elimination occurs in 4 -5 half life Half life of Aspirin is 4hrs, Digoxin =40 hrs, Digitoxin is 7 days. First order kinetics – t1/2 remains constant because V and CL do not change with dose Zero order kinetics – t1/2 increases with dose because CL progressively decreases as dose is increased (elimination process get saturated)

15. Half life is useful in estimating : • time to reach steady state concentration • duration of drug action • time for plasma concentration to fall after the drug has stopped • determine the frequency of drug administration

16. Single or few quickly repeated doses given in the beginning to attain target concentration rapidly • loading dose= Target Plasma conc X Vd bioavailability LOADING DOSE

17. Single dose – Loading dose Therapeutic level Plasma Concentration Repeated doses –Maintenance dose Time

18. Drugs are administered in such a way so as to maintain a steady state of drug in the body MAINTENANCE DOSE

19. Monitoring drug therapy by measuring plasma concentration of a drug for the benefit to patient by achieving maximum therapeutic benefit with minimum side effects. Therapeutic drug monitoring

20. With narrow therapeutic index/low safety margin Eg: Digoxin , Phenytoin, carbamazepine ,Gentamicin Antidepressants , Lithium. • Altered physiological states affecting drug concentration • Check patient compliance • Poisonings • Failure of drug response without any reason • Drug response • Used for adjustment of doses • To check bioavailability INDICATIONS

21. It is the combination of two or more drugs in a single pharmaceutical combination Advantages: • Increases patient compliance • Synergistic combination. Eg: Sulfamethoxazole + Trimethoprim: Cotrimoxazole Levodopa + Carbidopa: Parkinsonism Estrogen + Progesterone : Oral contraceptive • Reduced side effects - the side effect of one component may be counteracted by the another Eg: thiazide +potassium sparing diuretic FIXED DOSE COMBINATION

22. Reduced cost • Prevents emergence of antimicrobial resistance • Increased efficacy (produce Max effect of the drug) Disadvantages: • The patient may not actually need all the drugs present in a combination: he is subjected to additional side effects and expense . • Inflexible fixed dose ratio • Incompatible pharmacokinetics • Difficult to identify one particular drug causing harmful effect • Increased toxicity due to inappropriate combinations • Physician and pharmacists ignorance of the contents.

23. Levodopa + Carbidopa: Parkinsonism • Isoniazid + Rifampicin + Pyrazinamide: Tuberculosis. • Ferrous sulfate + Folic acid: Anemia of pregnancy. • Sulfamethoxazole + Trimethoprim: Cotrimoxazole. • Amoxicillin + Clavulanic acid: Augmentin. • Estrogen + Progesterone : Oral contraceptive • Aspirin + Codeine: As an analgesic. Fixed dose combination: FDC (Fixed dose ratio combinations) -

24. To decrease frequency of drug administration and improve compliance Avoiding large fluctuations in plasma concentration Maintaining the drug effect overnight without disturbance PROLONGATION OF DRUG ACTION

25. METHODS A. For orally administered drug: • Enteric coated e.g., erythromycin • Sustained release preparation e.g: Diclofenac B. For parenterally administered drug: 1) By decreasing the vascularity of the absorbing surface : This is achieved by adding a vasoconstrictor to the drug . Eg: Adrenaline with local anesthetics • Adrenaline prolongs the duration of action and reduce the systemic toxicity of local anesthetics. And also minimizes bleeding in the operative field . • Adding Adrenaline is contraindicated in cardiovascular disease patients .

26. 2) By decreasing the solubility : Decreasing the solubility of the drug by combining it with a water insoluble compound . Eg: Injection penicillin G has a duration of action of 4-6 hours Injection penicillin G +Procaine : procaine penicillin G has a duration of action of 12-24 hours and also less painful. 3) Injecting the drug in oily solution : Depot progestins (depot medroxy progesterone acetate ) 4) Pellet implantation : Norplant for contraception 5)Pilocarpine ocusert and progestasert 6)Transdermal patch

27. 7) By increasing the plasma protein binding of the drug : Eg: Sulphadiazine is less bound to plasma proteins and has duration of action of 6 hours . Sulphadoxine is highly protein bound and has a duration of action of one week 8) By inhibiting the drug metabolism : Anticholinesterases (Physostigmine ,neostigmine )prolongs the duration of action of Ach by inhibiting the cholinesterases 9) By delaying renal excretion of the drug : Probenecid prolongs duration of action of pencillin/Cephalosporins

28. Thank You